Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 51

1.

Mucosal Scalping of a Subepithelial Lesion: A Naked Colonic Lymphangioma.

Zimmer V, Eltze E.

ACG Case Rep J. 2019 May 10;6(5):e00074. doi: 10.14309/crj.0000000000000074. eCollection 2019 May. No abstract available.

2.

Low Numbers of Vascular Vessels Correlate to Progression in Hormone-Naïve Prostate Carcinomas Undergoing Radical Prostatectomy.

Smentoch J, Szade J, Żaczek AJ, Eltze E, Semjonow A, Brandt B, Bednarz-Knoll N.

Cancers (Basel). 2019 Sep 12;11(9). pii: E1356. doi: 10.3390/cancers11091356.

3.

Endoscopic resection of a prolapsing giant villous adenoma of the supraanal rectum.

Zimmer V, Eltze E.

Clin Res Hepatol Gastroenterol. 2020 Apr;44(2):121-122. doi: 10.1016/j.clinre.2019.07.007. Epub 2019 Aug 22. No abstract available.

PMID:
31447294
4.

Cold snare decapitation and blunt endoscopic dissection for tissue diagnosis of a gastric subepithelial lesion under direct vision.

Zimmer V, Eltze E.

Gastrointest Endosc. 2020 Jan;91(1):193-195. doi: 10.1016/j.gie.2019.07.029. Epub 2019 Aug 2. No abstract available.

PMID:
31381900
5.

BRCAness in prostate cancer.

Bednarz-Knoll N, Eltze E, Semjonow A, Brandt B.

Oncotarget. 2019 Mar 29;10(25):2421-2422. doi: 10.18632/oncotarget.26818. eCollection 2019 Mar 29. No abstract available.

6.

Granulation polyp arising in a former device-assisted full-thickness resection site: Another kind of clip artifact?

Zimmer V, Eltze E.

Gastrointest Endosc. 2019 Apr;89(4):893-894. doi: 10.1016/j.gie.2018.12.008. Epub 2018 Dec 18. No abstract available.

PMID:
30576650
7.

ALDH1-positive intratumoral stromal cells indicate differentiated epithelial-like phenotype and good prognosis in prostate cancer.

Nastały P, Filipska M, Morrissey C, Eltze E, Semjonow A, Brandt B, Pantel K, Bednarz-Knoll N.

Transl Res. 2019 Jan;203:49-56. doi: 10.1016/j.trsl.2018.08.007. Epub 2018 Sep 12.

PMID:
30287243
8.

Somatic aberrations of BRCA1 gene are associated with ALDH1, EGFR, and tumor progression in prostate cancer.

Omari A, Nastały P, Stoupiec S, Bałabas A, Dąbrowska M, Bielińska B, Huss S, Pantel K, Semjonow A, Eltze E, Brandt B, Bednarz-Knoll N.

Int J Cancer. 2019 Feb 1;144(3):607-614. doi: 10.1002/ijc.31905. Epub 2018 Oct 22.

9.

Blind Biobanking of the Prostatectomy Specimen: Critical Evaluation of the Existing Techniques and Development of the New 4-Level Tissue Extraction Model With High Sampling Efficacy.

Tolkach Y, Eminaga O, Wötzel F, Huss S, Bettendorf O, Eltze E, Abbas M, Imkamp F, Semjonow A.

Prostate. 2017 Mar;77(4):396-405. doi: 10.1002/pros.23278. Epub 2016 Nov 16.

PMID:
27862105
10.

Analysis of topographical distribution of prostate cancer and related pathological findings in prostatectomy specimens using cMDX document architecture.

Eminaga O, Semjonow A, Eltze E, Bettendorf O, Schultheis A, Warnecke-Eberz U, Akbarov I, Wille S, Engelmann U.

J Biomed Inform. 2016 Feb;59:240-7. doi: 10.1016/j.jbi.2015.12.009. Epub 2015 Dec 17.

11.

Comparison of structural genetics of non-schistosoma-associated squamous cell carcinoma of the urinary bladder.

Molitor M, Junker K, Eltze E, Toma M, Denzinger S, Siegert S, Knuechel R, Gaisa NT.

Int J Clin Exp Pathol. 2015 Jul 1;8(7):8143-58. eCollection 2015.

12.

Preoperative Serum Prostate-Specific Antigen Levels Vary According to the Topographical Distribution of Prostate Cancer in Prostatectomy Specimens.

Eminaga O, Hinkelammert R, Abbas M, Wötzel F, Eltze E, Bettendorf O, Boegemann M, Semjonow A.

Urology. 2015 Oct;86(4):798-804. doi: 10.1016/j.urology.2015.07.029. Epub 2015 Aug 6.

PMID:
26255036
13.

Exploring prostate cancer genome reveals simultaneous losses of PTEN, FAS and PAPSS2 in patients with PSA recurrence after radical prostatectomy.

Ibeawuchi C, Schmidt H, Voss R, Titze U, Abbas M, Neumann J, Eltze E, Hoogland AM, Jenster G, Brandt B, Semjonow A.

Int J Mol Sci. 2015 Feb 11;16(2):3856-69. doi: 10.3390/ijms16023856.

14.

Preoperative prostate-specific antigen isoform p2PSA ≤ 22.5 pg/ml predicts advanced prostate cancer in patients undergoing radical prostatectomy.

Eminaga O, Bögemann M, Breil B, Titze U, Wötzel F, Eltze E, Bettendorf O, Semjonow A.

Urol Oncol. 2014 Nov;32(8):1317-26. doi: 10.1016/j.urolonc.2014.04.018. Epub 2014 Jun 2.

PMID:
24893699
15.

Prostate cancers detected on repeat prostate biopsies show spatial distributions that differ from those detected on the initial biopsies.

Eminaga O, Hinkelammert R, Abbas M, Titze U, Eltze E, Bettendorf O, Wötzel F, Bögemann M, Semjonow A.

BJU Int. 2015 Jul;116(1):57-64. doi: 10.1111/bju.12691. Epub 2015 Apr 17.

16.

Tumor percentage but not number of tumor foci predicts disease-free survival after radical prostatectomy especially in high-risk patients.

Hinkelammert R, Eminaga O, Bettendorf O, Eltze E, Abbas M, Hertle L, Semjonow A.

Urol Oncol. 2014 May;32(4):403-12. doi: 10.1016/j.urolonc.2013.10.001. Epub 2013 Dec 12.

PMID:
24332639
17.

Genome-wide investigation of multifocal and unifocal prostate cancer-are they genetically different?

Ibeawuchi C, Schmidt H, Voss R, Titze U, Abbas M, Neumann J, Eltze E, Hoogland AM, Jenster G, Brandt B, Semjonow A.

Int J Mol Sci. 2013 Jun 3;14(6):11816-29. doi: 10.3390/ijms140611816.

18.

High-grade prostatic intraepithelial neoplasia (HGPIN) and topographical distribution in 1,374 prostatectomy specimens: existence of HGPIN near prostate cancer.

Eminaga O, Hinkelammert R, Abbas M, Titze U, Eltze E, Bettendorf O, Semjonow A.

Prostate. 2013 Jul;73(10):1115-22. doi: 10.1002/pros.22660. Epub 2013 Mar 26.

PMID:
23532797
19.

The presence of positive surgical margins in patients with organ-confined prostate cancer results in biochemical recurrence at a similar rate to that in patients with extracapsular extension and PSA ≤ 10 ng/ml.

Eminaga O, Hinkelammert R, Titze U, Abbas M, Eltze E, Bettendorf O, Semjonow A.

Urol Oncol. 2014 Jan;32(1):32.e17-25. doi: 10.1016/j.urolonc.2012.11.021. Epub 2013 Feb 19.

PMID:
23434425
20.

CMDX©-based single source information system for simplified quality management and clinical research in prostate cancer.

Eminaga O, Abbas M, Hinkelammert R, Titze U, Bettendorf O, Eltze E, Ozgür E, Semjonow A.

BMC Med Inform Decis Mak. 2012 Dec 3;12:141. doi: 10.1186/1472-6947-12-141.

Supplemental Content

Loading ...
Support Center